Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD)

November 2006

Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD).

About 5% of reproductive age women have this more severe form of premenstrual syndrome.

Yaz seems to help both physical AND emotional symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote